1. Balboni G, Lazzari I, Trapella C, Negri L, Lattanzi R, Giannini E, Nicotra A, Melchiorri P, Visentin S, Nuccio CD et al.. (2008) Triazine compounds as antagonists at Bv8-prokineticin receptors.
J Med Chem, 51 (23): 7635-9.
[PMID:19006379]
2. Battersby S, Critchley HO, Morgan K, Millar RP, Jabbour HN. (2004) Expression and regulation of the prokineticins (endocrine gland-derived vascular endothelial growth factor and Bv8) and their receptors in the human endometrium across the menstrual cycle.
J Clin Endocrinol Metab, 89 (5): 2463-9.
[PMID:15126578]
3. Beale K, Gardiner JV, Bewick GA, Hostomska K, Patel NA, Hussain SS, Jayasena CN, Ebling FJ, Jethwa PH, Prosser HM et al.. (2013) Peripheral administration of prokineticin 2 potently reduces food intake and body weight in mice via the brainstem.
Br J Pharmacol, 168 (2): 403-10.
[PMID:22935107]
4. Boulberdaa M, Turkeri G, Urayama K, Dormishian M, Szatkowski C, Zimmer L, Messaddeq N, Laugel V, Dollé P, Nebigil CG. (2011) Genetic inactivation of prokineticin receptor-1 leads to heart and kidney disorders.
Arterioscler Thromb Vasc Biol, 31 (4): 842-50.
[PMID:21273561]
5. Bullock CM, Li JD, Zhou QY. (2004) Structural determinants required for the bioactivities of prokineticins and identification of prokineticin receptor antagonists.
Mol Pharmacol, 65 (3): 582-8.
[PMID:14978236]
6. Chaly AL, Srisai D, Gardner EE, Sebag JA. (2016) The Melanocortin Receptor Accessory Protein 2 promotes food intake through inhibition of the Prokineticin Receptor-1.
Elife, 5.
[PMID:26829592]
7. Chen J, Kuei C, Sutton S, Wilson S, Yu J, Kamme F, Mazur C, Lovenberg T, Liu C. (2005) Identification and pharmacological characterization of prokineticin 2 beta as a selective ligand for prokineticin receptor 1.
Mol Pharmacol, 67 (6): 2070-6.
[PMID:15772293]
8. Cook IH, Evans J, Maldonado-Pérez D, Critchley HO, Sales KJ, Jabbour HN. (2010) Prokineticin-1 (PROK1) modulates interleukin (IL)-11 expression via prokineticin receptor 1 (PROKR1) and the calcineurin/NFAT signalling pathway.
Mol Hum Reprod, 16 (3): 158-69.
[PMID:19801577]
9. Denison FC, Battersby S, King AE, Szuber M, Jabbour HN. (2008) Prokineticin-1: a novel mediator of the inflammatory response in third-trimester human placenta.
Endocrinology, 149 (7): 3470-7.
[PMID:18372330]
10. Dorsch M, Qiu Y, Soler D, Frank N, Duong T, Goodearl A, O'Neil S, Lora J, Fraser CC. (2005) PK1/EG-VEGF induces monocyte differentiation and activation.
J Leukoc Biol, 78 (2): 426-34.
[PMID:15908459]
11. Evans J, Catalano RD, Morgan K, Critchley HO, Millar RP, Jabbour HN. (2008) Prokineticin 1 signaling and gene regulation in early human pregnancy.
Endocrinology, 149 (6): 2877-87.
[PMID:18339712]
12. Franchi S, Giannini E, Lattuada D, Lattanzi R, Tian H, Melchiorri P, Negri L, Panerai AE, Sacerdote P. (2008) The prokineticin receptor agonist Bv8 decreases IL-10 and IL-4 production in mice splenocytes by activating prokineticin receptor-1.
BMC Immunol, 9: 60.
[PMID:18957080]
13. Gasser A, Brogi S, Urayama K, Nishi T, Kurose H, Tafi A, Ribeiro N, Désaubry L, Nebigil CG. (2015) Discovery and cardioprotective effects of the first non-Peptide agonists of the G protein-coupled prokineticin receptor-1.
PLoS ONE, 10 (4): e0121027.
[PMID:25831128]
14. Guilini C, Urayama K, Turkeri G, Dedeoglu DB, Kurose H, Messaddeq N, Nebigil CG. (2010) Divergent roles of prokineticin receptors in the endothelial cells: angiogenesis and fenestration.
Am J Physiol Heart Circ Physiol, 298 (3): H844-52.
[PMID:20023120]
15. Hoffmann P, Feige JJ, Alfaidy N. (2006) Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy.
Endocrinology, 147 (4): 1675-84.
[PMID:16384869]
16. Hoogerwerf WA. (2006) Prokineticin 1 inhibits spontaneous giant contractions in the murine proximal colon through nitric oxide release.
Neurogastroenterol Motil, 18 (6): 455-63.
[PMID:16700725]
17. Jacobson O, Weiss ID, Niu G, Balboni G, Congiu C, Onnis V, Kiesewetter DO, Lattanzi R, Salvadori S, Chen X. (2011) Prokineticin receptor 1 antagonist PC-10 as a biomarker for imaging inflammatory pain.
J Nucl Med, 52 (4): 600-7.
[PMID:21421710]
18. Kisliouk T, Levy N, Hurwitz A, Meidan R. (2003) Presence and regulation of endocrine gland vascular endothelial growth factor/prokineticin-1 and its receptors in ovarian cells.
J Clin Endocrinol Metab, 88: 3700-3707.
[PMID:12915658]
19. Lattanzi R, Congui C, Onnis V, Deplano A, Salvadori S, Marconi V, Maftei D, Francisco A, Ambrosio C, Casella I, Costa T, Calatabiano G, Matsoukas MT, Balboni G, Negri L. (2014) Halogenated triazinediones behave as antagonists of PKR1: in vitro and in vivo pharmacological characterization.
Int J Pharm Sci Res, 5 (11): 5066-5074.
20. LeCouter J, Lin R, Frantz G, Zhang Z, Hillan K, Ferrara N. (2003) Mouse endocrine gland-derived vascular endothelial growth factor: a distinct expression pattern from its human ortholog suggests different roles as a regulator of organ-specific angiogenesis.
Endocrinology, 144 (6): 2606-16.
[PMID:12746324]
21. LeCouter J, Lin R, Tejada M, Frantz G, Peale F, Hillan KJ, Ferrara N. (2003) The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: Localization of Bv8 receptors to endothelial cells.
Proc Natl Acad Sci USA, 100 (5): 2685-90.
[PMID:12604792]
22. LeCouter J, Zlot C, Tejada M, Peale F, Ferrara N. (2004) Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization.
Proc Natl Acad Sci USA, 101 (48): 16813-8.
[PMID:15548611]
23. Lin DC, Bullock CM, Ehlert FJ, Chen JL, Tian H, Zhou QY. (2002) Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor.
J Biol Chem, 277 (22): 19276-80.
[PMID:11886876]
24. Martucci C, Franchi S, Giannini E, Tian H, Melchiorri P, Negri L, Sacerdote P. (2006) Bv8, the amphibian homologue of the mammalian prokineticins, induces a proinflammatory phenotype of mouse macrophages.
Br J Pharmacol, 147 (2): 225-34.
[PMID:16299550]
25. Masuda Y, Takatsu Y, Terao Y, Kumano S, Ishibashi Y, Suenaga M, Abe M, Fukusumi S, Watanabe T, Shintani Y et al.. (2002) Isolation and identification of EG-VEGF/prokineticins as cognate ligands for two orphan G-protein-coupled receptors.
Biochem Biophys Res Commun, 293 (1): 396-402.
[PMID:12054613]
26. Negri L, Lattanzi R, Giannini E, Colucci M, Margheriti F, Melchiorri P, Vellani V, Tian H, De Felice M, Porreca F. (2006) Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior.
J Neurosci, 26 (25): 6716-27.
[PMID:16793879]
27. Negri L, Lattanzi R, Giannini E, Metere A, Colucci M, Barra D, Kreil G, Melchiorri P. (2002) Nociceptive sensitization by the secretory protein Bv8.
Br J Pharmacol, 137 (8): 1147-54.
[PMID:12466223]
28. Ngan ES, Lee KY, Sit FY, Poon HC, Chan JK, Sham MH, Lui VC, Tam PK. (2007) Prokineticin-1 modulates proliferation and differentiation of enteric neural crest cells.
Biochim Biophys Acta, 1773 (4): 536-45.
[PMID:17324478]
29. O'Hayre M, Vázquez-Prado J, Kufareva I, Stawiski EW, Handel TM, Seshagiri S, Gutkind JS. (2013) The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer.
Nat Rev Cancer, 13 (6): 412-24.
[PMID:23640210]
30. Parker R, Liu M, Eyre HJ, Copeland NG, Gilbert DJ, Crawford J, Sutherland GR, Jenkins NA, Herzog H. (2000) Y-receptor-like genes GPR72 and GPR73: molecular cloning, genomic organisation and assignment to human chromosome 11q21.1 and 2p14 and mouse chromosome 9 and 6.
Biochim Biophys Acta, 1491 (1-3): 369-75.
[PMID:10760605]
31. Ralbovsky JL, Lisko JG, Palmer JM, Mabus J, Chevalier KM, Schulz MJ, Dyatkin AB, Miskowski TA, Coats SJ, Hornby P et al.. (2009) Triazinediones as prokineticin 1 receptor antagonists. Part 1: SAR, synthesis and biological evaluation.
Bioorg Med Chem Lett, 19 (10): 2661-3.
[PMID:19375913]
32. Rouault AAJ, Lee AA, Sebag JA. (2017) Regions of MRAP2 required for the inhibition of orexin and prokineticin receptor signaling.
Biochim Biophys Acta Mol Cell Res, 1864 (12): 2322-2329.
[PMID:28939058]
33. Ruiz-Ferrer M, Torroglosa A, Núñez-Torres R, de Agustín JC, Antiñolo G, Borrego S. (2011) Expression of PROKR1 and PROKR2 in human enteric neural precursor cells and identification of sequence variants suggest a role in HSCR.
PLoS ONE, 6 (8): e23475.
[PMID:21858136]
34. Soga T, Matsumoto Si, Oda T, Saito T, Hiyama H, Takasaki J, Kamohara M, Ohishi T, Matsushime H, Furuichi K. (2002) Molecular cloning and characterization of prokineticin receptors.
Biochim Biophys Acta, 1579 (2-3): 173-9.
[PMID:12427552]
35. Su MT, Lin SH, Chen YC, Wu LW, Kuo PL. (2013) Prokineticin receptor variants (PKR1-I379V and PKR2-V331M) are protective genotypes in human early pregnancy.
Reproduction, 146 (1): 63-73.
[PMID:23687280]
36. Urayama K, Guilini C, Messaddeq N, Hu K, Steenman M, Kurose H, Ert G, Nebigil CG. (2007) The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis.
FASEB J, 21 (11): 2980-93.
[PMID:17442730]
37. Urayama K, Guilini C, Turkeri G, Takir S, Kurose H, Messaddeq N, Dierich A, Nebigil CG. (2008) Prokineticin receptor-1 induces neovascularization and epicardial-derived progenitor cell differentiation.
Arterioscler Thromb Vasc Biol, 28 (5): 841-9.
[PMID:18421008]
38. Vellani V, Colucci M, Lattanzi R, Giannini E, Negri L, Melchiorri P, McNaughton PA. (2006) Sensitization of transient receptor potential vanilloid 1 by the prokineticin receptor agonist Bv8.
J Neurosci, 26 (19): 5109-16.
[PMID:16687502]
39. Wade PR, Palmer JM, Mabus J, Saunders PR, Prouty S, Chevalier K, Gareau MG, McKenney S, Hornby PJ. (2010) Prokineticin-1 evokes secretory and contractile activity in rat small intestine.
Neurogastroenterol Motil, 22 (5): e152-61.
[PMID:19930539]
